The main types include tumor infiltrating lymphocytes (TILs), chimeric antigen receptor T-cell therapy (CAR-T), T-cell receptor engineered T-cell therapy (TCR-T), and NK cell therapy [261]. Here, TBXT is linked to neoplasm.